78206-147Level 3
Ontruzant (trastuzumab)
**Product type:** Human Prescription Drug
**Active ingredient:** TRASTUZUMAB
**Strength:** 150 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Organon LLC
**Marketing category:** BLA (BLA761100)
**Pharmacologic class:** HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/78206-147Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.